May 29, 2012
Mylan Inc. said Tuesday it had settled a patent fight with Sunovion Pharmaceuticals Inc. over the asthma drug Xopenex, in a deal that will allow Mylan to continue selling its own version of the drug and release it from paying an $18 million damages award.